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Differential food protein‐induced inflammatory responses in 
swine lines selected for reactivity to soy antigens
To the Editor,
Food protein‐induced enterocolitis, commonly triggered by milk and 
soy protein, is on the rise, but immunological mechanisms of the dis‐
ease are poorly understood.1 Most animal models of food allergy uti‐
lize mice which have significant limitations in obtaining translatable 
information.2 Here, we report a novel porcine model of soy‐induced 
enteritis mimicking Food Protein‐Induced Enterocolitis Syndrome 
(FPIES) that mainly affects neonates and young children.3‐6 An 
advantage of using a swine model is their relative longer growing 
period during which induction and assessment of food allergy re‐
sponses can be studied.7 Moreover, higher similarities in anatomy, 
immunology, and diet are also useful characteristics. Our model uti‐
lizes two related pig lines (L1 and L2), created by selective breeding 
for 8 generations based on their low (L1) and high (L2) responses to 
soy proteins injected in the hypodermis.8 L2 animals develop eosin‐
ophilic enteritis similar to human FPIES upon sensitization and sub‐
sequent oral challenges with soy proteins, while L1 animals develop 
moderate neutrophilia in the small intestine but do not develop clin‐
ically overt inflammatory responses. Enhanced responses of soy‐re‐
active IL‐4‐producing CD4+ T and non‐T cells were detected in the 
intestine of L2, whereas low levels of Th2 but normal levels of Th1 
cells were detected in L1 animals.
To induce food allergy responses, L1 and L2 animals were sen‐
sitized 3 times with a soy extract and cholera toxin (i.p.), and then 
orally challenged with soy‐containing diet (Figure 1A). L1 and L2 
had different levels of inflammation in the jejunum. While both L1 
and L2 developed enteritis based on leukocyte infiltration in the je‐
junum, L2 developed a significantly higher inflammatory response, 
indicated by low villus heights and high mucosal layer destruction 
(Figure S1A, B; Figure 1B, C), which is reminiscent of the small intes‐
tinal lesions of certain FPIES patients.4‐6 Histological examination of 
the inflamed jejunum tissues revealed eosinophilic infiltration (some 
marked by black arrows), particularly in the lamina propria area of L2 
animals (Figure 1B). In contrast, mononuclear phagocytes and neu‐
trophils (green arrows) with small numbers of eosinophils infiltrated 
the jejunum of soy‐challenged L1 animals.
To more quantitatively examine leukocytes, we determined 
the frequency of the infiltrating eosinophils and neutrophils in the 
soy‐challenged animals by flow cytometry. SWC1+SIRP1α+ cells 
represent neutrophils, whereas SWC1− SIRP1α+ cells represent 
eosinophils in pigs.9 The frequency of eosinophils was greatly in‐
creased in the blood and jejunum of soy‐challenged L2 animals 
(Figur S2A; Figure 2A). In contrast, the frequency of neutrophils 
was increased in the jejunum of L1 animals upon soy challenge 
(Figure S2B).
GATA3 is a major transcription factor expressed by Th2 cells and 
innate type 2 lymphoid cells (ILC2). CCL11 is a chemoattractant for 
eosinophils. IL18 is also called interferon‐gamma inducing factor and 
associated with Th1 responses. In line with the eosinophil response, 
GATA3 and CCL11 were highly up‐regulated in the jejunum of L2, but 
IL18 expression was up‐regulated in the jejunum of L1 following soy 
challenge (Figure S3A). In addition, L2 had lower expression of IL17A 
compared to L1 (Figure S3B).
Next, we examined the levels of Th1 and Th2 effector cells. L1 
has higher steady‐state levels of Th1 cells in the blood. Soy chal‐
lenge decreased them in the blood but slightly increased them in 
the jejunum (Figure S3C, D). Th2 numbers were decreased in the 
blood of both lines following soy challenge but were considerably 
increased in the MLN and the jejunum of L2 animals only (Figure 
S3C; Figure 2B). Overall, the Th2/Th1 ratio was high in the blood of 
unchallenged and in the gut tissues of challenged L2 animals (Figure 
S3E). Soy challenge appears to shift effector T cells, particularly Th2 
cells, from the blood to gut tissues.
We also detected soy‐responsive CD4+ T cells and non‐CD4+ 
cells in the blood of L2 animals challenged with soy diet (Figure 
S4A). Only L2, but not L1, CD4+, and CD4‐ cells underwent pro‐
liferation ex vivo in the presence of soy antigens (Figure S4A; 
Figure 2C). These cells expressed IL‐4, but not IFN‐γ, at increased 
levels (Figure S4B). These results confirm that L2 animals have 
increased numbers of soy protein‐reactive Th2 cells. Non‐T cells, 
such as innate lymphoid cells (ILCs), can also produce the Th1/2 
cytokines. IL‐4‐, but not IFN‐γ−, expressing CD3‐ non‐T cells were 
also increased in the jejunum of L2 (Figure S5A, B). L2 had higher 
frequencies of FoxP3+ T cells than L1 animals upon soy challenges 
(Figure S5C, D). Thus, Tregs were not quantitatively suppressed in 
the L2 animals.
Importantly, soy‐fed L2 animals displayed retarded growth 
during the 20‐day feeding period (Figure 2D). Flow cytometry ex‐
amination of intestinal tissues revealed increased frequencies of 
Th2, Th1, and FoxP3+ T cells in the jejunum of soy‐fed L2 pigs (not 
shown). These results indicate that natural soy exposure through the 
oral route can cause adverse immune responses in the intestine of 
L2 animals, leading to decreased growth performance.
We have established a swine model of food allergy. This model 
will be particularly useful in studying food protein‐induced allergy 
responses in the intestine. This model is unique in that it employs 
two swine lines with a ~12% genetic relatedness among individual 
animals. Therefore, this model better mimics the genetically het‐
erogeneous human populations. The two lines were different in 
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immune responses to soy proteins in terms of Th2 cells, eosinophils, 
and non‐T cell IL‐4 producers, which could be ILC2. Thus, the two 
lines represent individuals with high and low susceptibility to food 
protein‐induced inflammatory responses. Especially, the L2 animals 
have heavy infiltration with eosinophils and Th2 cells in the small 
intestine, thus similar to the eosinophil type FPIES.4‐6 We demon‐
strated that the increased sensitivity to soy antigens can deterio‐
rate animal health evidenced by retarded growth. This model will 
be highly useful for developing pharmaceuticals for prevention or 
treatments of food allergy responses. It can also serve as a testing 
model for developing hypo‐allergenic foods including baby formulas 
and animal feeds. Future work includes generation of stable lines for 
in‐depth immunological and genetic studies to understand underly‐
ing mechanisms.
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F I G U R E  1   Differential soy‐induced 
inflammatory responses in two pig lines. 
A, The soy challenge group was sensitized 
with immunization i.p. with soy protein 
extract (300 μg) and cholera toxin (CT, 
20 μg) and then challenged with 28% 
soy meal. Control groups received CT 
only without soy proteins and were not 
challenged with soy. B, Representative 
histological images of jejunum of L1 
and L2 pigs with eosinophil counts in 
challenged animals. Representative 
eosinophils (black) and mononuclear 
cells/neutrophils (green) are highlighted 
with arrows. C, Severe cases of intestinal 
inflammation in L2 animals. *Significant 
differences (P < 0.05; n = 8 per group)
(A)
(B)
(C)
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The presence of virus significantly associates with chronic 
rhinosinusitis disease severity
 To the Editor,
Chronic rhinosinusitis (CRS) is an inflammatory disorder of the para‐
nasal sinuses occurring with and without nasal polyps (CRSsNP and 
CRSwNP). Although not objectively demonstrated, an initial viral in‐
sult is commonly described by patients prior to the development of 
CRS. If viruses were demonstrated to play a role in CRS, novel pro‐
phylactic and/or therapeutic targets might be uncovered.
Findings in previous studies investigating CRS and viruses are 
variable.1‐4 Possible reasons include small sample sizes, unvalidated 
collection methods, seasonal limitation, heterogenous CRS cohorts, 
and limited viral species screening. No studies to date have investi‐
gated disease severity in relation to viral presence.
We aimed to investigate the sinonasal virome of patients with CRS 
in relation to disease phenotype, to compare it to healthy controls, 
and to explore any association between more severe disease and viral 
presence. Cytobrush samples were taken from the sinonasal passages, 
and DNA/RNA extracts underwent PCR for a number of viral species 
and strains. The Herpesviridae were excluded due to their near‐ubiq‐
uity in adult sinuses. Methodology details appear in the Data S1.
A total of 288 patients were recruited: 71 controls, 133 CRSsNP, 
and 84 CRSwNP (Table S1). Of the 288, 45 patients were virus‐pos‐
itive: 5 control, 27 CRSsNP, and 13 CRSwNP (Figure 1). The rate of 
viral positivity was significantly higher in the CRSsNP group (P < 0.05).
Objective disease severity scores (Lund‐Mackay [LMS] and Lund‐
Kennedy [LKS]) revealed significantly worse disease in the CRSsNP 
virus‐positive cohort compared with the CRSsNP virus‐negative co‐
hort (P < 0.05, Figure 2). No significant differences were observed 
in the control or CRSwNP cohorts. Subjective scores (Sino‐Nasal 
Outcome Test 22 [SNOT‐22] and Adelaide Disease Severity Score 
[ADSS]) revealed no difference between patients with or without 
virus in any of the groups (Figure 2). PCR cycle thresholds also re‐
vealed no difference between virus‐positive or virus‐negative indi‐
viduals (Table S2). Viral species detected did not vary significantly 
from the previously published studies; these were largely rhinovirus 
and coronavirus (Tables S2 and S3 and Figure S1). Peak viral detec‐
tion occurred in spring and winter; there was no significant differ‐
ence in detection when analyzed by season (Figure S2).
This study identified common respiratory viruses as more prev‐
alent in patients with CRSsNP than in controls. It is the first study to 
demonstrate their significant association with more severe radiolog‐
ical and endoscopic disease in virus‐positive CRSsNP patients but not 
virus‐positive patients with CRSwNP.
The lack of any significant difference in subjective symptom scores 
in any of the groups is not unexpected. The absence of correlation be‐
tween subjective and objective measures of disease severity has been 
well documented.5 Although the inclusion of nonrhinologic questions 
in the SNOT‐22 score is a possible explanation, no difference was ob‐
served when using the more specific ADSS. Another possible expla‐
nation may be the timing of sampling. As most viruses tested in the 
assay are shed from the nasopharynx up to 3 weeks after symptom 
resolution, it is possible that sampling occurred either during this time 
or early in the infection prior to symptom development.
The viruses identified largely were consistent with those seen 
in previous CRS studies, with the exception that this study did not 
identify metapneumovirus. The main viruses observed across all 
cohorts were rhinovirus and coronavirus, with influenza featuring 
strongly in the CRS group. However, it seems likely there is no one 
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